Dr. Kevin Cullen is director of the University of Maryland Greenebaum Cancer Center
Baltimore, MD – March 14, 2011. Kevin J. Cullen, M.D., director of the University of Maryland Marlene and Stewart Greenebaum Cancer Center, and professor of medicine at the University of Maryland School of Medicine, has been selected by President Barack Obama to serve on the National Cancer Advisory Board, an advisory committee to the U.S. National Cancer Institute (NCI). The appointment will be for six years.
Dr. Cullen, a head and neck cancer specialist, is one of five people the president appointed to the cancer advisory board. “These dedicated individuals bring a wealth of experience and talent to their new roles and I am proud to have them serve in this Administration. I look forward to working with them in the months and years to come,” President Obama said.
The National Cancer Advisory Board advises the secretary of the U.S. Department of Health and Human Services and the NCI director on issues that relate to the activities of the institute, including reviewing and recommending support grants and cooperative agreements. It consists of 18 members appointed by the president from leading health and scientific disciplines as well as other fields such as economics, public policy, health policy, economics, management and the environment.
Dr. Cullen has been the director of the University of Maryland Marlene and Stewart Greenebaum Cancer Center since January 2004. Under his leadership, the cancer center has significantly expanded its clinical and research programs and was named an NCI-designated cancer center in 2008. The Greenebaum Cancer Center is part of the University of Maryland Medical Center and University of Maryland School of Medicine.
“Dr. Cullen is an outstanding clinician and physician-scientist with an impressive record as the leader of our cancer center. He will bring a wide range of knowledge to this important leadership position on the National Cancer Advisory Board, and I heartily congratulate him on this much-deserved honor,” says E. Albert Reece, M.D., Ph.D., M.B.A., vice president of medical affairs at the University of Maryland and dean of the University of Maryland School of Medicine.
Before coming to the University of Maryland, Dr. Cullen was affiliated with the Lombardi Cancer Center at Georgetown University in Washington, D.C., for 15 years and served as interim director for two years. He was a professor of medicine, oncology and otolaryngology at the Georgetown University School of Medicine.
Dr. Cullen serves on the national board of the American Cancer Society and on the external advisory boards of several NCI-designated cancer centers. He is the author of numerous journal publications and has served on review panels for the NCI, the Veterans Administration Research Program and other organizations. He has received the NCI’s Special Achievement Award, the American Cancer Society South Atlantic Division Service Award and the Ulman Cancer Fund for Young Adults Hope Award. He has been named a Top Doctor by Baltimore and Washingtonian magazines.
A graduate of Dartmouth College and Harvard Medical School, Dr. Cullen completed his internship and residency at Beth Israel Hospital in Boston and received additional training at the NCI.